Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

Sky to axe hundreds of jobs - report

(Sharecast News) - Hundreds of job are set to be cut at Sky, it was reported on Tuesday, as the broadcaster looks to improve existing services following a stream of product launches.

According to the Financial Times, citing unnamed people familiar with the plans, around 900 jobs will be affected.

Around 600 jobs will be lost, with people in another 300 roles redeployed elsewhere within Sky.

Sky, which is based in west London, is owned by US media giant Comcast. It currently employs around 23,000 people in the UK.

In recent years it has massively expanded the range of products and services it offers, including the smart TV Sky Glass and streaming service Sky Stream.

However, a source told the FT that with the product development phase complete, the focus now was "more about improving what we already have".

Sky told the newspaper: "As we look ahead, we are shifting our approach to bring customers the next generation of experience by investing in digital-first service, unbeatable content and even better performance from our products."

Comcast acquired Sky in 2018, beating rival bidder Disney in a mammoth £31bn deal.

According to the most recently available set of accounts, in 2023 Sky posted pre-tax losses of £773m on revenues of £10.2bn, after it wrote down £1.2bn in loans to its German and Italian operations.

The firm has already sought to cut costs, including axing 2,000 customer service positions in March and 1,000 roles last year.

Last year's job cuts were primarily in engineering, as customers increasingly migrate to digital services which do not require a satellite dish.

Share this article

Related Sharecast Articles

GSK gets preliminary nod for two respiratory drugs in Europe
(Sharecast News) - GSK said on Friday afternoon that two of its respiratory medicines had received positive opinions from the European Medicines Agency's Committee for Medicinal Products for Human Use, bringing the company closer to potential approvals across severe asthma, chronic rhinosinusitis with nasal polyps and chronic obstructive pulmonary disease.
Shore Capital hails improved US biotech funding environment for hVIVO
(Sharecast News) - Shares in AIM-listed hVIVO were continuing their recent surge on the back of encouraging signs from the US biotech market, which broker Shore Capital said has created a "much more favourable environment" for the company.
Weir to buy remaining 50% stake in Chile JV ESEL for £56m
(Sharecast News) - Weir said on Friday that it has agreed to buy the remaining 50% share of its Chile-based joint venture ESEL for a sterling equivalent purchase price of £56m.
Jefferies downgrades Whitbread, upgrades IHG
(Sharecast News) - Jefferies downgraded Whitbread to 'hold' from 'buy' on Friday as it applied the reverse upgrade to InterContinental Hotels.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.